CHJTF
Price
$0.64
Change
+$0.02 (+3.23%)
Updated
Apr 10 closing price
Capitalization
9.91B
CMOPF
Price
$55.00
Change
-$7.80 (-12.42%)
Updated
Apr 10 closing price
Capitalization
827.91M
Ad is loading...

CHJTF vs CMOPF

Header iconCHJTF vs CMOPF Comparison
Open Charts CHJTF vs CMOPFBanner chart's image
CSPC Pharmaceuticals Group
Price$0.64
Change+$0.02 (+3.23%)
Volume$78.39K
Capitalization9.91B
Cosmo Pharmaceuticals
Price$55.00
Change-$7.80 (-12.42%)
Volume$200
Capitalization827.91M
CHJTF vs CMOPF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CHJTF vs. CMOPF commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHJTF is a Hold and CMOPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (CHJTF: $0.64 vs. CMOPF: $55.00)
Brand notoriety: CHJTF and CMOPF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHJTF: 4% vs. CMOPF: 60%
Market capitalization -- CHJTF: $9.91B vs. CMOPF: $827.91M
CHJTF [@Pharmaceuticals: Major] is valued at $9.91B. CMOPF’s [@Pharmaceuticals: Major] market capitalization is $827.91M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHJTF’s FA Score shows that 2 FA rating(s) are green whileCMOPF’s FA Score has 1 green FA rating(s).

  • CHJTF’s FA Score: 2 green, 3 red.
  • CMOPF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHJTF is a better buy in the long-term than CMOPF.

Price Growth

CHJTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while CMOPF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.16%. For the same industry, the average monthly price growth was -2.53%, and the average quarterly price growth was -8.74%.

Reported Earning Dates

CHJTF is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

FUNDAMENTALS
Fundamentals
CHJTF($9.91B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than CHJTF: CMOPF (68.49) vs CHJTF (11.52). CHJTF YTD gains are higher at: 8.181 vs. CMOPF (-17.819). CHJTF has higher annual earnings (EBITDA): 7.63B vs. CMOPF (42.1M). CHJTF has more cash in the bank: 13.4B vs. CMOPF (222M). CMOPF has less debt than CHJTF: CMOPF (176M) vs CHJTF (683M). CHJTF has higher revenues than CMOPF: CHJTF (31.1B) vs CMOPF (104M).
CHJTFCMOPFCHJTF / CMOPF
Capitalization9.91B828M1,197%
EBITDA7.63B42.1M18,114%
Gain YTD8.181-17.819-46%
P/E Ratio11.5268.4917%
Revenue31.1B104M29,904%
Total Cash13.4B222M6,036%
Total Debt683M176M388%
FUNDAMENTALS RATINGS
CHJTF vs CMOPF: Fundamental Ratings
CHJTF
CMOPF
OUTLOOK RATING
1..100
4739
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4356
PRICE GROWTH RATING
1..100
4786
P/E GROWTH RATING
1..100
29100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (12) in the null industry is in the same range as CHJTF (20). This means that CMOPF’s stock grew similarly to CHJTF’s over the last 12 months.

CMOPF's Profit vs Risk Rating (100) in the null industry is in the same range as CHJTF (100). This means that CMOPF’s stock grew similarly to CHJTF’s over the last 12 months.

CHJTF's SMR Rating (43) in the null industry is in the same range as CMOPF (56). This means that CHJTF’s stock grew similarly to CMOPF’s over the last 12 months.

CHJTF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for CMOPF (86). This means that CHJTF’s stock grew somewhat faster than CMOPF’s over the last 12 months.

CHJTF's P/E Growth Rating (29) in the null industry is significantly better than the same rating for CMOPF (100). This means that CHJTF’s stock grew significantly faster than CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLOZX7.740.13
+1.71%
Cohen & Steers Future of Energy Z
CVMIX17.80N/A
N/A
Calvert Emerging Markets Equity I
VVOIX19.40N/A
N/A
Invesco Value Opportunities Y
GCCLX15.85N/A
N/A
GMO Climate Change I
LYRZX12.50N/A
N/A
Lyrical International Value Equity C

CHJTF and

Correlation & Price change

A.I.dvisor tells us that CHJTF and CSPCY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHJTF and CSPCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHJTF
1D Price
Change %
CHJTF100%
N/A
CSPCY - CHJTF
23%
Poorly correlated
+0.16%
DSKYF - CHJTF
7%
Poorly correlated
+6.29%
CHGCF - CHJTF
1%
Poorly correlated
-32.69%
CMOPF - CHJTF
-0%
Poorly correlated
N/A
DSNKY - CHJTF
-0%
Poorly correlated
+0.69%
More

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and GSK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and GSK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
GSK - CMOPF
22%
Poorly correlated
+1.27%
NVS - CMOPF
21%
Poorly correlated
+0.94%
CHGCY - CMOPF
7%
Poorly correlated
+1.73%
DSNKY - CMOPF
5%
Poorly correlated
+0.69%
CSPCY - CMOPF
4%
Poorly correlated
+0.16%
More